Skip to main content

Table 2 Multivariable cox proportional analysis of incidence and predictors of LTFU among women under Option B+ PMTCT at Nekemte Specialized Hospital, western Ethiopia, 2013–2019

From: Incidence and predictors of lost to follow-up among women under Option B+ PMTCT program in western Ethiopia: a retrospective follow-up study

Variables

Category

Survival status

CHR

AHR

p-value

LTFU

Censored

No (%)

No (%)

Educational level

No education

22 (43.1)

63 (22.6)

3.95 (1.87–8.35)

4.01 (1.84–8.76)

< 0.001*

Primary

19 (37.3)

94 (33.7)

2.23 (1.03–4.81)

1.63 (0.72–3.68)

0.232

Secondary and above

10 (19.6)

122 (43.7)

1

1

 

Residence

Rural

34 (66.7)

97 (34.8)

3.43 (1.91–6.14)

2.80 (1.54–5.08)

0.001*

Urban

17 (33.3)

182 (65.2)

1

1

 

Disclosure status

No

29 (56.9)

56 (20.1)

4.15 (2.38–7.24)

2.80 (1.50–5.22)

0.001*

Yes

22 (43.1)

223 (79.9)

1

1

 

Partner HIV status

Positive

8 (15.6)

98 (35.1)

1

1

 

Negative

24 (47.1)

113 (40.5)

2.25 (1.01–5.01)

2.27 (0.97–4.87)

0.059

Unknown

19 (37.3)

68 (24.4)

3.26 (1.42–7.45)

1.90 (0.79–4.52)

0.146

Status of women on enrollment

Pregnant

39 (76.5)

249 (89.2)

1

1

 

Lactating

12 (23.5)

30 (10.8)

3.62 (1.84–7.09)

4.10 (2.03–8.28)

<0.001*

Previous history of HIV

Yes

20 (39.2)

201 (75.7)

1

1

 

No

31 (60.8)

78 (24.3)

3.84 (2.18–6.75)

3.04 (1.59–5.80)

0.001*

Hemoglobin

≤12.0

19 (37.3)

143 (51.3)

1

1

 

≥12.1

32 (62.7)

136 (48.7)

1.67 (0.95–2.96)

1.77 (0.97–3.25)

0.061

Recent adherence

Good

41 (80.4)

256 (91.8)

1

1

 

Fair/poor

10 (19.6)

23 (8.2)

2.40 (1.20–4.80)

2.80 (1.29–6.07)

0.009*

Baseline regimen

TDF/3TC/EFV

42 (82.4)

198 (80.0)

1

  

AZT/3TC/NVP

6 (11.8)

45 (16.1)

0.60 (0.25–1.43)

1.11 (0.43–2.85)

0.815

AZT/3TC/EFV

3 (5.8)

36 (12.9)

0.40 (0.12–1.29)

0.44 (0.12–1.52)

0.198

  1. CHR crude hazard ratio, AHR adjusted hazard